Clinical Trials Browser

Borderline Resectable Pancreatic Cancer × S 1 (combination) × Clear all

NCT03850769 2020-03-10

Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Borderline Resectable Pancreatic Cancer